Litigation Details for Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2016)
✉ Email this page to a colleague
Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-06-29 |
Court | District Court, D. Delaware | Date Terminated | 2018-08-21 |
Cause | 35:271 Patent Infringement | Assigned To | Kent A. Jordan |
Jury Demand | None | Referred To | |
Patents | 6,987,102; 7,897,590; RE42,152 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc.
Details for Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-08-21 | 109 | Judgment | ofU.S. Patent No. 6,987,102 ("the '102 patent") and claims 8 and 19 ofU.S. Patent No., …claim 8 of the '1 02 patent and claims 8 and 19 of the '590 patent, to the extent that those…claim 8 of the '1 02 patent and claims 8 and 19 ofthe '590 patent, and the use, sale, or offer…claim 8 of the '1 02 patent and claims 8 and 19 of the '590 patent, and because those claims…, 7,897,590 ("the '590 patent") are invalid due to derivation (or anticipation), obviousness | External link to document |
2018-08-21 | 111 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,897,590 B2 ;US 6,987,102 B2. (nmg)…2016 21 August 2018 1:16-cv-00540 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |